About Us

A Breakthrough in Cancer Therapy

We have developed an innovative cancer treatment using magnetosomes, which are administered to tumors and heated by applying an alternating magnetic field. This method of treatment is called magnetic hyperthermia. The heat released by the magnetosomes induces antitumor activity.

Magnetosomes possess advantageous properties compared with their chemically synthesized counterparts, including a larger size leading to better heating properties and a chain arrangement that provides homogeneous heating.

We have already carried out two proofs of concept of our therapy in breast cancer and glioblastoma using mouse models. Of particular note, we demonstrated complete eradication of tumors in murine models of glioblastoma following treatment.

Our Team Members

The AlphaOnco team combines deep scientific expertise with strategic business insights, creating a unique synergy that drives the development of transformative cancer therapies. This multidisciplinary team includes leading researchers, clinicians, and engineers who bring cutting-edge innovations to life, alongside business professionals experienced in navigating the biotechnology landscape, forming strategic alliances, and scaling impactful healthcare solutions.

Supported by a network of world-class advisors and experts in oncology, nanotechnology, and biotechnology, AlphaOnco is positioned at the forefront of scientific and commercial excellence. This strong collaboration enables the team to tackle complex challenges with precision, advancing their mission of delivering groundbreaking cancer treatments to improve patient outcomes globally.